BlackRock Institutional Trust’s Adverum Biotechnologies ADVM Stock Holding History

BlackRock Institutional Trust’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.39M	Buy	47,884 +2,151	+5%	+$70.3K	﹤0.01%	3184
2016 Q3	$1.88M	Buy	45,733 +2,413	+6%	+$91.5K	﹤0.01%	3078
2016 Q2	$1.37M	Buy	43,320 +1,345	+3%	+$60.8K	﹤0.01%	3191
2016 Q1	$2.17M	Sell	41,975 -173	-0.4%	-$9.66K	﹤0.01%	3005
2015 Q4	$4.01M	Sell	42,148 -551	-1%	-$48.4K	﹤0.01%	2830
2015 Q3	$3.52M	Buy	42,699 +13,079	+44%	+$1.67M	﹤0.01%	2875
2015 Q2	$4.81M	Buy	29,620 +7,836	+36%	+$2.64M	﹤0.01%	2781
2015 Q1	$8.83M	Buy	21,784 +12,764	+142%	+$5.4M	﹤0.01%	2465
2014 Q4	$4.87M	Buy	9,020 +3,289	+57%	+$1.27M	﹤0.01%	2742
2014 Q3	$1.96M	Buy	+5,731	New	+$1.71M	﹤0.01%	3085

Other funds holding ADVM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Institutional Trust's ADVM Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Adverum Biotechnologies (ADVM) stake by 4.7% in Q4 2016, buying an estimated $70.3K and bringing the position to 47,884 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #3184.

BlackRock Institutional Trust first reported a position in ADVM in Q3 2014 and has held it in 10 quarters since. The position peaked at $8.83M in Q1 2015. 83 funds tracked by Wall St. Rank hold ADVM as of Q4 2016.

BlackRock Institutional Trust held 47,884 shares of Adverum Biotechnologies worth $1.39M as of Q4 2016.
BlackRock Institutional Trust bought 2,151 Adverum Biotechnologies shares in Q4 2016, an estimated $70.3K.
Adverum Biotechnologies made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3184 holding.
BlackRock Institutional Trust first reported a position in Adverum Biotechnologies in Q3 2014 and has held it in 10 quarters since.
BlackRock Institutional Trust's Adverum Biotechnologies position peaked at $8.83M in Q1 2015.
83 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.